Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer

被引:11
|
作者
Narukawa, Tsukasa [1 ]
Hara, Tomohiko [1 ]
Arai, Eri [2 ]
Komiyama, Motokiyo [1 ]
Kawahara, Takashi [1 ]
Kanai, Yae [2 ]
Fujimoto, Hiroyuki [1 ]
机构
[1] Natl Canc Ctr, Div Urol, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan
关键词
urology; urologic-med; upper urinary tract urothelial carcinoma; ureteral cancer; renal pelvic cancer; intravesical recurrence; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; CUMULATIVE INCIDENCE; COMPETING RISK; MODEL; MULTICENTER; PREVENTION; LOCATION; IMPACT; TRIALS;
D O I
10.1093/jjco/hyv019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Patients with upper urinary tract urothelial carcinoma (UUT-UC) without a history of bladder cancer have a different natural history of intravesical recurrence after nephroureterectomy compared with those with a history of bladder cancer. The aim of this study was to identify predictive factors for post-operative intravesical recurrence in patients with non-metastatic upper urinary tract-localized urothelial carcinoma without a history of bladder cancer and who were not taking medication during the perioperative period. Methods: This retrospective study included 133 patients who were treated between 1995 and 2012. Univariate and multivariate analyses were used to evaluate the clinical and pathological factors associated with the cumulative incidence of bladder cancer. Results: Of the 133 patients, 51 (38.3%) developed intravesical recurrence during a median follow-up of 71 months (range, 0.8-210.8). In the multivariate analysis, multifocality (P = 0.03) and high tumour grade (P = 0.007) were significantly associated with the cumulative incidence of bladder cancer. We constructed a prediction classification model on the basis of the total number of risk factors. The 2-year cumulative incidence rates were 5.6, 34.8 and 50.0% in individuals with no, one and two risk factors, respectively. There was a significant difference between patients with no risk factors and those with two risk factors (P = 0.01). Conclusions: Although this retrospective study had several limitations, tumour multifocality and tumour grade were found to be potential risk factors for intravesical recurrence in our cases.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [11] THE IMPACT OF INTRAVESICAL RECURRENCE ON PROGNOSIS AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CELL CARCINOMA
    Inokuchi, Junichi
    Kuroiwa, Kentaro
    Tatsugami, Katsunori
    Yokomizo, Akira
    Naito, Seiji
    JOURNAL OF UROLOGY, 2012, 187 (04): : E262 - E263
  • [12] Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma
    Yamashita, Shinichi
    Ito, Akihiro
    Mitsuzuka, Koji
    Tochigi, Tatsuo
    Namima, Takashige
    Soma, Fumihiko
    Aizawa, Masataka
    Ioritani, Naomasa
    Kaiho, Yasuhiro
    Arai, Yoichi
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 378 - 384
  • [13] USING MICRORNA TO PREDICT BLADDER RECURRENCE AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA
    Levy, Alison
    Sullivan, Travis
    Browne, Brendan
    Stensland, Kristian
    Burks, Eric
    Patel, Chintan
    Warrick, Joshua
    Raman, Jay
    Canes, David
    Rieger-Christ, Kimberly
    JOURNAL OF UROLOGY, 2018, 199 (04): : E215 - E215
  • [14] Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma
    Lee, Jong Hoon
    Lee, Chung Un
    Chung, Jae Hoon
    Song, Wan
    Kang, Minyong
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Sung, Hyun Hwan
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03):
  • [15] Intravesical irrigation might prevent bladder recurrence in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma
    Yamamoto, Satoshi
    Sakamoto, Shinichi
    Imamura, Yusuke
    Sazuka, Tomokazu
    Nakamura, Kazuyoshi
    Inoue, Toshihito
    Chiba, Kazuto
    Miyazaki, Kanetaka
    Inoue, Atsushi
    Nagata, Maki
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (08) : 791 - 796
  • [16] URINARY PH IS HIGHLY ASSOCIATED WITH BLADDER RECURRENCE AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS WITH POSITIVE SMOKING HISTORY
    Ide, Hiroki
    Kikuchi, Eiji
    Tanaka, Nobuyuki
    Miyajima, Akira
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2015, 193 (04): : E13 - E13
  • [17] Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy
    Fujita, Kazutoshi
    Ujike, Takeshi
    Nagahara, Akira
    Uemura, Motohide
    Tanigawa, Go
    Shimazu, Kohki
    Fushimi, Hiroaki
    Yamaguchi, Seiji
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (05) : 463 - 467
  • [18] The Utility of UroVysion® as an Intravesical Recurrence Predictor after Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract
    Iwata, Hidehiro
    Sassa, Naoto
    Kato, Mashashi
    Hattori, Ryohei
    Takahara, Taishi
    Goto, Momokazu
    Tsuzuki, Toyonori
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 377 - 377
  • [19] The Utility of UroVysion® as an Intravesical Recurrence Predictor after Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract
    Iwata, Hidehiro
    Sassa, Naoto
    Kato, Mashashi
    Hattori, Ryohei
    Takahara, Taishi
    Goto, Momokazu
    Tsuzuki, Toyonori
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 377 - 377
  • [20] Diagnostic Ureteroscopy Independently Correlates with Intravesical Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
    Luo, Hao Lun
    Kang, Chih Hsiung
    Chen, Yen Ta
    Chuang, Yao Chi
    Lee, Wei Ching
    Cheng, Yuan Tso
    Chiang, Po Hui
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (09) : 3121 - 3126